Revvity, Inc. (RVTY)
122.92
-1.83
(-1.47%)
USD |
NYSE |
Aug 24, 16:00
122.92
0.00 (0.00%)
After-Hours: 20:00
Revvity Enterprise Value : 16.24B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 16.24B |
| August 20, 2026 | 16.17B |
| August 19, 2026 | 15.65B |
| August 18, 2026 | 15.01B |
| August 17, 2026 | 15.28B |
| August 14, 2026 | 15.36B |
| August 13, 2026 | 15.43B |
| August 12, 2026 | 15.47B |
| August 11, 2026 | 15.23B |
| August 10, 2026 | 15.26B |
| August 07, 2026 | 15.11B |
| August 06, 2026 | 15.07B |
| August 05, 2026 | 15.15B |
| August 04, 2026 | 14.75B |
| August 03, 2026 | 15.17B |
| July 31, 2026 | 14.87B |
| July 30, 2026 | 14.99B |
| July 29, 2026 | 14.97B |
| July 28, 2026 | 14.76B |
| July 27, 2026 | 14.38B |
| July 24, 2026 | 14.64B |
| July 23, 2026 | 14.95B |
| July 22, 2026 | 14.65B |
| July 21, 2026 | 14.65B |
| July 20, 2026 | 14.19B |
| Date | Value |
|---|---|
| July 17, 2026 | 14.61B |
| July 16, 2026 | 14.78B |
| July 15, 2026 | 14.74B |
| July 14, 2026 | 14.73B |
| July 13, 2026 | 14.72B |
| July 10, 2026 | 14.85B |
| July 09, 2026 | 14.92B |
| July 08, 2026 | 14.52B |
| July 07, 2026 | 14.82B |
| July 06, 2026 | 14.92B |
| July 02, 2026 | 15.01B |
| July 01, 2026 | 14.91B |
| June 30, 2026 | 14.73B |
| June 29, 2026 | 14.90B |
| June 26, 2026 | 15.11B |
| June 25, 2026 | 15.16B |
| June 24, 2026 | 14.28B |
| June 23, 2026 | 13.64B |
| June 22, 2026 | 13.55B |
| June 18, 2026 | 13.65B |
| June 17, 2026 | 13.41B |
| June 16, 2026 | 13.79B |
| June 15, 2026 | 13.71B |
| June 12, 2026 | 13.61B |
| June 11, 2026 | 13.82B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 46.42B |
| Danaher Corp. | 177.35B |
| Thermo Fisher Scientific, Inc. | 271.27B |
| Waters Corp. | 45.42B |
| Bio-Rad Laboratories, Inc. | 9.912B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 53.48M |
| Revenue (Quarterly) | 729.69M |
| Total Expenses (Quarterly) | 676.21M |
| EPS Diluted (Quarterly) | 0.4642 |
| Gross Profit Margin (Quarterly) | 50.26% |
| Profit Margin (Quarterly) | 7.33% |
| Earnings Yield | 1.71% |
| Operating Earnings Yield | 3.24% |
| Normalized Earnings Yield | 2.285 |